NASDAQ
Albireo Pharma, Inc. (ALBO) has a current ratio of 5.93x as of Monday, May 25, 2026. This represents a 37.34% decrease compared to its 12-month average of 9.47x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.